Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Malignant Lymphoma

  Free Subscription


18.05.2020

1 Am J Surg Pathol
1 Blood
1 BMC Cancer
2 Bone Marrow Transplant
7 Br J Haematol
1 J Clin Oncol
3 Leuk Lymphoma
3 Leukemia
1 N Engl J Med
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Surg Pathol

  1. MELCHERS RC, Willemze R, van de Loo M, van Doorn R, et al
    Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.
    Am J Surg Pathol. 2020;44:776-781.
    PubMed         Abstract available


    Blood

  2. JELINEK T, Zuchnicka J
    Peripheral T-cell lymphoma, NOS, with rapidly progressing leukocytosis mimicking acute lymphoblastic leukemia.
    Blood. 2020;135:1816.
    PubMed        


    BMC Cancer

  3. AKPA CA, Kleo K, Oker E, Tomaszewski N, et al
    Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma model.
    BMC Cancer. 2020;20:427.
    PubMed         Abstract available


    Bone Marrow Transplant

  4. LIN RJ, Ho C, Devlin SM, Ruiz JD, et al
    Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma.
    Bone Marrow Transplant. 2020 May 13. pii: 10.1038/s41409-020-0942.
    PubMed        

  5. DAMLAJ M, Abuelgasim KA, Alhejazi A, Alahmari B, et al
    Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma.
    Bone Marrow Transplant. 2020 May 13. pii: 10.1038/s41409-020-0935.
    PubMed        


    Br J Haematol

  6. EPPERLA N
    What is the optimal reduced-intensity conditioning regimen for patients with classical Hodgkin lymphoma undergoing allogeneic transplantation? - is there a one to use or avoid.
    Br J Haematol. 2020 May 9. doi: 10.1111/bjh.16726.
    PubMed        

  7. CALIMERI T, Ferreri AJM
    Prevention of CNS relapse in diffuse large B-cell lymphoma: common sense prevails where science fails.
    Br J Haematol. 2020 May 12. doi: 10.1111/bjh.16719.
    PubMed        

  8. PEPRAH S, Ogwang MD, Kerchan P, Reynolds SJ, et al
    Mean platelet counts are relatively decreased with malaria but relatively increased with endemic Burkitt Lymphoma in Uganda, Tanzania, and Kenya.
    Br J Haematol. 2020 May 12. doi: 10.1111/bjh.16700.
    PubMed         Abstract available

  9. SONNEVI K, Wasterlid T, Melen CM, Harrysson S, et al
    Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study.
    Br J Haematol. 2020 May 12. doi: 10.1111/bjh.16737.
    PubMed         Abstract available

  10. LEE S, Fujita K, Morishita T, Negoro E, et al
    Prognostic utility of a geriatric nutritional risk index in combination with a comorbidity index in elderly patients with diffuse large B cell lymphoma.
    Br J Haematol. 2020 May 14. doi: 10.1111/bjh.16743.
    PubMed         Abstract available

  11. MASSARO F, Stepanishyna Y, Manni M, Luminari S, et al
    Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma.
    Br J Haematol. 2020 May 14. doi: 10.1111/bjh.16714.
    PubMed         Abstract available

  12. KIMBY E, Lockmer S, Holte H, Hagberg H, et al
    The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy.
    Br J Haematol. 2020 May 14. doi: 10.1111/bjh.16692.
    PubMed         Abstract available


    J Clin Oncol

  13. NASTOUPIL LJ, Jain MD, Feng L, Spiegel JY, et al
    Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.
    J Clin Oncol. 2020 May 13:JCO1902104. doi: 10.1200/JCO.19.02104.
    PubMed         Abstract available


    Leuk Lymphoma

  14. FUSEYA H, Yoshida M, Oyama R, Tatsumi N, et al
    Mantle cell lymphoma with dot-like nuclear staining for cyclin D1.
    Leuk Lymphoma. 2020 May 12:1-4. doi: 10.1080/10428194.2020.1759050.
    PubMed        

  15. GAO C, Harrop S, Van Der Weyden C, McCormack C, et al
    Primary cutaneous anaplastic large cell lymphoma and evolving clinical practice: 26 years of skin lesions with locoregional progression to systemic disease.
    Leuk Lymphoma. 2020 May 12:1-3. doi: 10.1080/10428194.2020.1761972.
    PubMed        

  16. LANAMTIENG T, Teawtrakul N, Ungarreevittaya P
    Prevalence and clinical characteristics of EBV-positive diffuse large B-cell lymphoma in adult patients: a single center study in Thailand.
    Leuk Lymphoma. 2020 May 14:1-3. doi: 10.1080/10428194.2020.1765240.
    PubMed        


    Leukemia

  17. REUTTER K, Sandmann S, Rohde J, Muller S, et al
    Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma.
    Leukemia. 2020 May 14. pii: 10.1038/s41375-020-0862.
    PubMed        

  18. YOUNG KH
    Good prognosis or poor prognosis, dose-intensive or less intensive: who decides for adults with T-lymphoblastic lymphoma/leukemia.
    Leukemia. 2020 May 12. pii: 10.1038/s41375-020-0861.
    PubMed        

  19. ATTARBASCHI A, Carraro E, Ronceray L, Andres M, et al
    Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents.
    Leukemia. 2020 May 11. pii: 10.1038/s41375-020-0841.
    PubMed         Abstract available


    N Engl J Med

  20. LI C, Huang B
    CAR-Transduced Natural Killer Cells.
    N Engl J Med. 2020;382:1865-1866.
    PubMed        


    Proc Natl Acad Sci U S A

  21. NAGASAKA M, Yamagishi M, Yagishita N, Araya N, et al
    Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Proc Natl Acad Sci U S A. 2020 May 11. pii: 1920346117.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: